Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Mycosis Fungoides × trastuzumab biosimilar HLX02 × Clear all

Sponsor

Conditions

Breast Neoplasms 4 Malignant Solid Neoplasm 1 Inflammatory Breast Neoplasms 1 Esophageal Neoplasms 1 Carcinoma, Intraductal, Noninfiltrating 1 Breast Neoplasms, Male 1 Bladder Urothelial Carcinoma 1 Advanced Breast Carcinoma 1 Adenocarcinoma Of Esophagus 1

Interventions

fludarabine phosphate 16 Whole-Body Irradiation 13 Mycophenolic Acid 13 Peripheral Blood Stem Cell Transplantation 12 Cyclosporine 10 Cyclophosphamide 10 Tacrolimus 9 Antilymphocyte Serum 9 Busulfan 8 Methotrexate 7 Etoposide 6 Rituximab 5 Melphalan 5 Flow Cytometry 5 Lenalidomide 4 Filgrastim 4 Everolimus 4 Dexamethasone 4 Calcium Dobesilate 4 Bexarotene 4 thymoglobulin 3 romidepsin 3 pembrolizumab 3 hypericin 3 Therapeutics 3 Sirolimus 3 Radiotherapy 3 Panobinostat 3 In Situ Hybridization, Fluorescence 3 Immunohistochemistry 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡